Fast-Cath Hemostasis Introducer 12 cm Sheath 4 F 9 F
|
|
|
- Stephen Perry
- 6 years ago
- Views:
Transcription
1 Fast-Cath Hemostasis Introducer 4 F 9 F Close tolerance extrusion and proprietary tipping process facilitate tracking on a guidewire Convenient suture rings to secure sheath during catheter manipulation or during prolonged vascular access Patented valve preserves catheter handling characteristics while minimizing backbleeding and air inspiration Snap lock feature secures dilator in sheath during insertion Contents: Introducer Sheath with Hemostasis Valve and Sideport, Dilator, and 150 cm Double Distal Guidewire with J and straight ends (10 units per box) Guidewire Diameter (in) Sheath Usable Length (cm) Standard.038 Guidewire Small Guidewire Introducers St. Jude Medical. All Rights Reserved. Page 1
2 Fast-Cath Hemostasis Introducer 4 F 9 F Close tolerance extrusion and proprietary tipping process facilitate tracking on a guidewire Convenient suture rings to secure sheath during catheter manipulation or during prolonged vascular access Patented valve preserves catheter handling characteristics while minimizing backbleeding and air inspiration Snap lock feature secures dilator in sheath during insertion Contents: Cath-Lock Introducer Sheath with Hemostasis Valve and Sideport, Dilator, and 50 cm Double Distal Guidewire with J and straight ends (10 units per box) Guidewire Diameter (in) Sheath Usable Length (cm) Page St. Jude Medical. All Rights Reserved.
3 Fast-Cath Duo Hemostasis Introducer 8 F 12 F Two catheter access reduces the need for multiple punctures Contents: 2 Port Hemostasis Adapter with Sideports and Cath-Lock sealing mechanism, Venous Sheath, Dilator and 50 cm Double Distal guidewire with J and straight ends (5 units per box) Guidewire Diameter (in) Sheath Usable Length (cm) Catheter (2) 4 F (2) 5 F (2) 6 F 2013 St. Jude Medical. All Rights Reserved. Page 3
4 Fast-Cath Duo Hemostasis Introducer 23 cm Sheath 9 F Two catheter access reduces the need for multiple punctures Contents: 2 Port Hemostasis Adapter with Sideports and Cath-Lock sealing mechanism, Venous Sheath, Dilator and 80 cm Double Distal Guidewire with J and straight ends (5 units per box) Guidewire Diameter (in) Sheath Usable Length (cm) Catheter (1) 4 F & (1) 5 F Page St. Jude Medical. All Rights Reserved.
5 Fast-Cath Trio Hemostasis Introducer 10 F 14 F Three catheter access reduces the need for multiple punctures Contents: 3 Port Hemostasis Adapter with Sideports and Cath-Lock sealing mechanism, Venous Sheath, Dilator and 50 cm Double Distal Guidewire with J and straight ends (5 units per box) Guidewire Diameter (in) Sheath Usable Length (cm) Catheter (2) 4 F & (1) 5 F (2) 5 F & (1) 7 F (2) 6 F & (1) 7 F 2013 St. Jude Medical. All Rights Reserved. Page 5
6 Fast-Cath Trio Hemostasis Introducer 23 cm Sheath 10 F Three catheter access reduces the need for multiple punctures Contents: 3 Port Hemostasis Adapter with Sideports and Cath-Lock sealing mechanism, Venous Sheath, Dilator and 80 cm Double Distal Guidewire with J and straight ends (5 units per box) Guidewire Diameter (in) Sheath Usable Length (cm) Catheter (2) 4 F & (1) 5 F Page St. Jude Medical. All Rights Reserved.
Teleflex Incorporated Investor Presentation Q3 2015
Teleflex Incorporated Investor Presentation Q3 2015 Important Information 2 Forward Looking Statements This presentation and our discussion contain forward-looking information and statements, including,
Second Quarter Report and Merit News 2008 MERIT MEDICAL SYSTEMS, INC.
Second Quarter Report and Merit News 2008 MERIT MEDICAL SYSTEMS, INC. MERIT MEDICAL SYSTEMS, INC. President s Letter to Shareholders Dear Fellow Shareholders: Merit Medical Systems, Inc. reported record
Part 5 Medical devices for coronary stenting
Crown Agents Reference: CA/107403/0005/001 (REVISED) Date: 2 February 2017 (RE-ISSUE DATE) Dear Sirs BID CLOSING DATE 10 February 2017 at 13:00hrs UK time (GMT) AT CROWN AGENTS SUTTON, UK INVITATION TO
Hydratome. Cannulating Sphincterotome
Hydratome RX Cannulating Sphincterotome RX Biliary System A difference you can feel. The endoscope shows you the way, but it s your sense of touch that gets you where you need to go. The devices that make
Teleflex Incorporated Investor Presentation J.P. Morgan 2016 Healthcare Conference
Teleflex Incorporated Investor Presentation J.P. Morgan 2016 Healthcare Conference Important Information 2 Forward Looking Statements This presentation and our discussion contain forward-looking information
Part 4 Medical Devices for Neurosurgical Treatment
Crown Agents Reference: CA/107403/0004/001 (REVISED) Date: 2 February 2017 (RE-ISSUE DATE) Dear Sirs BID CLOSING DATE 9 February 2017 at 13:00hrs UK time (GMT) AT CROWN AGENTS SUTTON, UK INVITATION TO
Ø mm. SYSTEM KAN-therm. High quality for reasonable price TECHNOLOGIA SUKCESU ISO 9001
Ø 16 110 mm SYSTEM KAN-therm PP High quality for reasonable price TECHNOLOGIA SUKCESU System KAN-therm PP - assortment pipe PN10 (S5/SDR11) GROUP: L 20 1,9 1229 202002 04000120 4/200 m 25 2,3 1229 202004
Instructions for Use Reprocessed Laparoscope Accessories (Scissors, Dissectors, Graspers)
Reprocessed by Instructions for Use Reprocessed Laparoscope Accessories (Scissors, Dissectors, Graspers) Reprocessed Device for Single Use Caution: Federal (U.S.A.) law restricts this device to sale by
Control your coverage. Control your drift. All with one tip.
Control your coverage. Control your drift. All with one tip. COMBO-JET ER, SR, MR & DR Droplet Selective Tip-Caps deliver consistent and proven drift reduction while providing a choice level of coverage
3. 510(k) SUMMARY OCT
3. 510(k) SUMMARY OCT 082008 This summary of510(k) safety and effectiveness information is submitted in accordance with the requirements of SMDA 1990 and 21 CFR 807.92. Applicant Information: 510(k)Number:
Portfolio. Cordis. AQUATRACK Hydrophilic Nitinol Guidewire. FRONTRUNNER XP CTO Catheter. ELITECROSS TM Support Catheter
Cordis CROSSING At Cordis Corporation, we re committed to providing the most comprehensive offering of reliable and powerful crossing tools in the industry that help you deliver the outcomes patients are
AngioDynamics Reports 2015 Second Quarter Financial Results
January 8, 2015 AngioDynamics Reports 2015 Second Quarter Financial Results Second Quarter Fiscal 2015 Net Sales increased 4% to $92.1 million; 5% sales growth excluding supply agreement GAAP EPS of $0.04;
Investigation of Interaction between Guidewire and Native Vessel Using Finite Element Analysis
Visit the SIMULIA Resource Center for more customer examples. Investigation of Interaction between Guidewire and Native Vessel Using Finite Element Analysis Atul Gupta 1, Subham Sett 2, Srinivasan Varahoor
Portfolio CORDIS. FRONTRUNNER XP CTO Catheter. AQUATRACK Hydrophilic Nitinol Guidewire. OUTBACK TM Elite Re-Entry Catheter
Elite Re-Entry Catheter FRONTRUNNER XP CTO Catheter AQUATRACK Hydrophilic Nitinol Guidewire NO CROSS GUARANTEE At cordis, we re committed to providing the most comprehensive offering of reliable and powerful
(12) United States Patent
US008114031B2 (12) United States Patent Marsman () Patent No.: (45) Date of Patent: Feb. 14, 2012 (54) FACILITATION OF ANTEGRADE INSERTION OF A GUIDEWIRE INTO THE SUPERFICIAL FEMORAL ARTERY (76) Inventor:
ST JUDE MEDICAL, LLC
ST JUDE MEDICAL, LLC FORM 10-K (Annual Report) Filed 02/26/15 for the Period Ending 01/03/15 Address ONE ST JUDE MEDICAL DRIVE ST PAUL, MN, 55117 Telephone 6517562000 CIK 0000203077 SIC Code 3845 - Electromedical
Teleflex Incorporated 2013 Analyst Day Jake Elguicze Treasurer and Vice President of Investor Relations
Teleflex Incorporated 2013 Analyst Day Jake Elguicze Treasurer and Vice President of Investor Relations Agenda 2 Strategic Overview Benson Smith Chairman, President & Chief Executive Officer Gross Margin
RST INSTRUMENTS LTD.
RST INSTRUMENTS LTD. Borehole Pressure Cell Installation Instructions Ltd. 200 2050 Hartley Avenue Coquitlam, B.C. Canada V3K 6W5 Tel: (604) 540-1100 Fax: (604) 540-1005 e-mail: info@rstinstruments.com
NOTICE INVITING TENDER
BHOPAL MEMORIAL HOSPITAL & RESEARCH CENTRE Under Department of Health Research, Ministry of Health & Family Welfare, Government of India Raisen Bye Pass Road, BHOPAL 462 038 (M. P.) Ph. No. 2742212-16
TELEFLEX INCORPORATED THIRD QUARTER 2015 EARNINGS CONFERENCE CALL
TELEFLEX INCORPORATED THIRD QUARTER 2015 EARNINGS CONFERENCE CALL 1 Conference Call Logistics The release, accompanying slides, and replay webcast are available online at www.teleflex.com (click on Investors
PN List Price $ Racer Decal Discount $
LOWE Industries PO Box 180 Rosewood, Qld 4340 Australia www.kenlowe.com.au Phone 0411-699 535 Solenoid Control Valve For use with air or CO2 supply. 12 volt control and dual acting feeds when on and when
ABOUT ENDOLOGIX, INC. ENDOLOGIX CORPORATE VISION POWERLINK SYSTEM BEST-IN-CLASS, LONG-TERM CLINICAL DATA
ABOUT ENDOLOGIX, INC. Endologix is a developer and manufacturer of minimally invasive treatments for vascular diseases. Endologix is focusing on the development and marketing of its patented technology
On behalf of our entire management team, we thank you for your support during a difficult year.
March 28, 2005 Dear Stockholder: This past year has been a challenging one for ICU Medical. We started 2004 expecting to continue at record revenue and net income levels. However, we ran into a temporary
Intellisight University of St. Thomas School of Law Minneapolis, MN. August 15, 2018
Intellisight 2018 University of St. Thomas School of Law Minneapolis, MN August 15, 2018 Safe Harbor FORWARD LOOKING STATEMENTS This presentation contains forward-looking statements within the meaning
INVITATION FOR BID ATTENTION: This is not an order. Read all instructions, terms and conditions carefully.
An Equal Opportunity University INVITATION FOR BID ATTENTION: This is not an order. Read all instructions, terms and conditions carefully. INVITATION NO.: UK-1891-19 RETURN ONE ORIGINAL COPY AND ONE CD
Teleflex Incorporated (NYSE: TFX) Jeffrey P. Black, Chairman and Chief Executive Officer Kevin K. Gordon, Executive Vice President and Chief
Teleflex Incorporated (NYSE: TFX) Jeffrey P. Black, Chairman and Chief Executive Officer Kevin K. Gordon, Executive Vice President and Chief Financial Officer Forward-Looking Statements This presentation
Payment Policy: Status B Bundled Services Reference Number: CC.PP.046 Product Types: ALL
Payment Policy: Reference Number: CC.PP.046 Product Types: ALL Effective Date: 01/01/2014 Last Review Date: 03/10/2018 Coding Implications Revision Log See Important Reminder at the end of this policy
ICU MEDICAL INC/DE FORM 10-K. (Annual Report) Filed 02/20/09 for the Period Ending 12/31/08
ICU MEDICAL INC/DE FORM 10-K (Annual Report) Filed 02/20/09 for the Period Ending 12/31/08 Address 951 CALLE AMANECER SAN CLEMENTE, CA 92763 Telephone 949-366-2183 CIK 0000883984 Symbol ICUI SIC Code 3841
(12) Patent Application Publication (10) Pub. No.: US 2015/ A1
US 2015O1 19923A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2015/0119923 A1 Liberatore et al. (43) Pub. Date: Apr. 30, 2015 (54) ENHANCED GRIPPING FEATURES FOR A6B 7/00 (2006.01)
Neovasc Inc. Management s Discussion and Analysis Form F1
Neovasc Inc. Management s Discussion and Analysis Form 51-102F1 FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2015 AND 2014 Q2 2015 FORM 51-102F1: MANAGEMENT S DISCUSSION AND ANALYSIS This discussion and
Coding and Billing Guide
To control prolonged air leaks of the lung or significant air leaks likely to become prolonged following lobectomy, segmentectomy and LVRS Coding and Billing Guide This guide is intended to provide coding
1st Quarter Financial Results for FYE/Mar Terumo Corporation July 30, 2009
1st Quarter Financial Results for FYE/Mar 2010 Terumo Corporation July 30, 2009 1 Financial Results (Unit: Billion yen) Q1 FYE/Mar. 2009 Q1 FYE/Mar. 2010 Rate of change Net Sales 77.8 77.5 0% Gross profit
Tender. For Infant Laparoscopy Instrument Set for the Department of Pediatrics Surgery
Tender For Infant Laparoscopy Instrument Set for the Department of Pediatrics Surgery At All India Institute of Medical Sciences, Jodhpur NIT Issue Date : 03 rd April, 016 NIT No. : Pre-Bid Meeting : 17
Financial Results for the First Half of. the Fiscal Year Ending March 31, 2014 (FY2013) Terumo Corporation November 6, 2013
Financial Results for the First Half of the Fiscal Year Ending March 31, 2014 (FY2013) Terumo Corporation November 6, 2013 Highlights in 1H Corporate Cardiac & Vascular Blood Management General Hospital
Teleflex Incorporated. First Quarter 2017 Earnings Conference Call
Teleflex Incorporated First Quarter 2017 Earnings Conference Call 1 Conference Call Logistics The release, accompanying slides, and replay webcast are available online at www.teleflex.com (click on Investors
AbbVie J. INTESTINAL TUBE 9 FR for PEG 15 and 20 FR. Rx Only. For enteral use only Store at room temperature AV
AbbVie J INTESTINAL TUBE 9 FR for PEG 15 and 20 FR For enteral use only Store at room temperature 62918-001 AV062-001 Rx Only Catalog number Sterilized using ethylene oxide Do not re-use Do not use if
SMART Repair Insurance. PSL Professional
SMART Repair Insurance PSL Professional Module Objective By the end of this module you will be able to complete an online assessment which will demonstrate your: Knowledge of SMART Repair Insurance Competence
SVL. 250 For full technical and ordering information visit
SVL Glassware l SVL glassware has screwthread joints which are easily connected together using purpose made couplings l Only glass and PTFE come into contact with the chemicals being used to provide a
AngioDynamics Reports Fiscal 2018 Fourth Quarter and Full-Year Financial Results
AngioDynamics Reports Fiscal 2018 Fourth Quarter and Full-Year Financial Results July 11, 2018 Fiscal 2018 Fourth Quarter Highlights Net sales of $88.3 million, an increase of 1.6% year over year Gross
TITAN MEDICAL INC. MANAGEMENT S DISCUSSION AND ANALYSIS FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2018 (IN UNITED STATES DOLLARS)
TITAN MEDICAL INC. MANAGEMENT S DISCUSSION AND ANALYSIS FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2018 (IN UNITED STATES DOLLARS) This Management s Discussion and Analysis ( MD&A ) is dated August 10,
ST JUDE MEDICAL, LLC
ST JUDE MEDICAL, LLC FORM 10-K (Annual Report) Filed 02/26/13 for the Period Ending 12/29/12 Address ONE ST JUDE MEDICAL DRIVE ST PAUL, MN, 55117 Telephone 6517562000 CIK 0000203077 SIC Code 3845 - Electromedical
March Process Industry Practices Piping. PIP PNDMV09N Needle Valve Data Sheet and Standard Terms
March 2013 Process Industry Practices Piping Needle Valve Data Sheet and Standard Terms PURPOSE AND USE OF PROCESS INDUSTRY PRACTICES In an effort to minimize the cost of process industry facilities, this
Financial Results for the Fiscal Year Ended March 31, 2010 Outlook for the Fiscal Year Ending March 31, Terumo Corporation May 12, 2010
Financial Results for the Fiscal Year Ended March 31, 2010 Outlook for the Fiscal Year Ending March 31, 2011 Terumo Corporation May 12, 2010 1 Net Sales Gross Profit SG&A Expenses Operating Income Ordinary
BIO-VASCULAR, INC. annual report Securing the Future
BIO-VASCULAR, INC. annual report 1999 Securing the Future financial highlights (in thousands, except per share data) SUMMARY STATEMENTS OF OPERATIONS DATA: BRANDED SURGICAL PRODUCTS The company s branded
Merkel Omegat OMS-MR PR
Merkel Omegat OMS-MR PR Merkel Omegat OMS-MR PR O-ring Pressure relief boring PTFE profile ring Injection moulding machines, mills, agricultural machinery, presses, earth moving equipment, large cylinders,
Press Information. June 28, 2017
Press Information June 28, 2017 Philips to acquire The Spectranetics Corporation to accelerate expansion in imageguided therapy devices to treat cardiac and peripheral vascular disease Highly complementary
Disclosure Slide. Why this topic? Numbers for Nurses: ASC Accounting and Finance. Derek Preece, MBA Principal and Executive Consultant, BSM Consulting
Derek Preece, MBA Principal and Executive Consultant, BSM Consulting Maureen Waddle, MBA Principal and Senior Consultant, BSM Consulting April 28, 2014 Boston, MA Disclosure Slide Numbers for Nurses: ASC
CH-PP polypropylene schedule 80 pipe, valves & fittings black and chem-pure natural
polypropylene schedule 80 pipe, valves & fittings black and chem-pure natural CH-PP-0410 Effective April 12, 2010 Supercedes CH-PP-0908R dated Sept. 29, 2008 SOCKET FITTINGS Suggested list prices subject
All Rights Reserved.
e n O t e nt e G, um r t s e OFF ical In For, n O rg g u n i S y k % e o h u o T 0 L B 5 t Have ou Are CTURE FA U! AN u o M Y ill r o W e It F Y n o D e If W W GerVetUSA Div of GerMed 1188 Willis Avenue
EXHIBIT D-1 SPECIAL CONDITIONS
EXHIBIT D-1 SPECIAL CONDITIONS 1. Mitigation Measures Developer shall comply with all applicable mitigation measures, as follows, adopted by any public agency with respect to this Project pursuant to the
Penumbra, Inc. (ExactNameofRegistrantasSpecifiedinItsCharter) Delaware (State or Other Jurisdiction of Incorporation or Organization)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended
T-25/C-25 SHINDAIWA ILLUSTRATED PARTS LIST PIEZAS DE REPUESTO LE RÉPERTOIRE DES PIÈCES ILLUSTRÉES C-25 CYLINDER/CILINDRO/CYLINDRE
SHINDAIWA T-25/C-25 T-25 ILLUSTRATED PARTS LIST PIEZAS DE REPUESTO LE RÉPERTOIRE DES PIÈCES ILLUSTRÉES C-25 A CYLINDER/CILINDRO/CYLINDRE C-CJ8 BM6A A1 20005-12110 20000-12220 11022-05200 (2) A2 20000-12212
2007 Datascope Corp. Annual Report
Introducing NetGuard 2007 Datascope Corp. Annual Report 2007 To Our Stockholders In this year s report, I would like to focus on a number of initiatives that Datascope has taken over the past year. We
Terumo Corporation IFRS Financial Results for the Fiscal Year Ended March 31, 2018
Terumo Corporation IFRS Financial Results for the Fiscal Year Ended March 31, 2018 1 2 4. Consolidated Financial Statements 1 Consolidated Statements of Financial Position Assets Current assets As of April
2Q18 Earnings Conference Call. August 2, 2018
2Q18 Earnings Conference Call August 2, 2018 Presentation of Financial Information & Forward-Looking Statements Historical financial and operating data in this presentation reflect the consolidated results
Tender. For Pediatric Laparoscopy Instrument Set for the Department of Pediatric Surgery
Tender For Pediatric Laparoscopy Instrument Set for the Department of Pediatric Surgery At All India Institute of Medical Sciences, Jodhpur NIT Issue Date : 03 rd April, 016 NIT No. : Admn/Tender/36/017-AIIMS.JDH
Second Quarter 2018 Earnings Results
Second Quarter 2018 Earnings Results August 1, 2018 Finn, VNS Therapy Patient Safe Harbor Certain statements in this presentation, other than purely historical information, are forward-looking statements
Market Trends: Volume to Value. Payment for dialysis access procedures in 2016 and beyond. Controlling costs. Fee for Service Coding Changes
Market Trends: Volume to Value Reimbursement is changing from payments based on fee-for-service (FFS) (volume) to a more value-based system and will shift some risk from payors to providers. Payment for
The Boiler and Pressure Vessel Fees Regulations, 1981
BOILER AND PRESSURE VESSEL FEES B-5 REG 1 1 The Boiler and Pressure Vessel s Regulations, 1981 Repealed by Chapter B-5.1 Reg 1 (effective January 1, 2007) Formerly Chapter B-5 Reg 1 (effective January
ST JUDE MEDICAL, LLC
ST JUDE MEDICAL, LLC FORM 10-K (Annual Report) Filed 02/26/14 for the Period Ending 12/28/13 Address ONE ST JUDE MEDICAL DRIVE ST PAUL, MN, 55117 Telephone 6517562000 CIK 0000203077 SIC Code 3845 - Electromedical
4Q18 Earnings Conference Call
4Q18 Earnings Conference Call February 21, 2019 ITGR: 4Q18 Earnings Conference Call / February 21, 2019 / Page 1 Presentation of Financial Information & Forward-Looking Statements Historical financial
NATIONAL INSTRUMENT TRADING RULES TABLE OF CONTENTS
Note: [10 Apr 2017] - The following is a consolidation of NI 23-101. It incorporates the amendments to this document that came into effect on December 31, 2003, December 31, 2006, September 12, 2008, January
ABBOTT PARK, Ill., Jan. 25, 2017 /PRNewswire/ -- Abbott (NYSE: ABT) today announced financial results for the fourth quarter ended Dec. 31, 2016.
Abbott Reports Fourth-Quarter 2016 Results - FOURTH-QUARTER GAAP EPS FROM CONTINUING OPERATIONS OF $0.51; ADJUSTED EPS FROM CONTINUING OPERATIONS OF $0.65 - ISSUES EPS OUTLOOK FOR 2017, REFLECTING DOUBLE-DIGIT
Canaccord Genuity 6 th Annual Cardiovascular, Aesthetics & Metabolic Disorders Medical Devices Conference December 6, 2011
D. Ashley Lee, EVP, COO & CFO Canaccord Genuity 6 th Annual Cardiovascular, Aesthetics & Metabolic Disorders Medical Devices Conference December 6, 2011 Forward Looking Statements Statements made in this
Tire & Wheel Protection Platinum with Key Replacement Vehicle Protection Plan. Backed by the Strength and Stability of Toyota
Tire & Wheel Protection Platinum with Key Replacement Vehicle Protection Plan Backed by the Strength and Stability of Toyota ESTIMATED COSTS WITHOUT WITH REPLACEMENT OF A DAMAGED TIRE $200 $0 REPLACEMENT
Section H Special Contract Requirements
Section H Special Contract Requirements 1. AGAR 452.209-70, ORGANIZATIONAL CONFLICTS OF INTEREST (FEB 1988). (a) The Contractor warrants that, to the best of the Contractor s knowledge and belief, there
Small Business Opportunity (SBO) Installers Agreement
Small Business Opportunity (SBO) Installers Agreement Entered into between Self Sealing Tyre Technology (SSTT) (Supplier) 1177 Leader Rd, Unit 8 Main Reef Industrial Estate Stormill, Roodepoort (011) 472
Centrifugal pumps. Medium flow rates PERFORMANCE RANGE INSTALLATION AND USE APPLICATION LIMITS OPTIONALS AVAILABLE ON REQUEST
HF Centrifugal pumps Medium flow rates PERFORMANCE RANGE Flow rate up to 600 l/min (36 m³/h) Head up to 39 m APPLICATION LIMITS Manometric suction lift up to 7 m Liquid temperature between -10 C and +90
Edwards Lifesciences Annual Report
Edwards Lifesciences 2013 Annual Report COMPANY DESCRIPTION Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring. Driven by a passion to help patients, we
QTY DESCRIPTION ALL PER ATTACHED SPECIFICATIONS UNIT PRICE
CITY OF HUTCHINSON BID FORM Please quote your delivered prices to the City of Hutchinson on items or services listed below. Consult attached minimum and general specifications for requirements. This is
Global Days Policy, Professional
REIMBURSEMENT POLICY Global Days Policy, Professional Policy Number 2018R0005D Annual Approval Date 7/11/2018 Approved By Reimbursement Policy Oversight Committee IMPORTANT NOTE ABOUT THIS REIMBURSEMENT
THE IMPLEMENTATION GUIDELINE TO THE DUO-KOREA 2018 FELLOWSHIP PROGRAM
THE IMPLEMENTATION GUIDELINE TO THE DUO-KOREA 2018 FELLOWSHIP PROGRAM This Implementation Guideline to the DUO-Korea 2018 Fellowship Program has been established by the Secretariat for the ASEM-DUO Fellowship
Through our close collaboration with physicians, Endologix. will be the leading innovator of treatments for aortic disorders.
2 0 0 9 A N N U A L R E P O R T Through our close collaboration with physicians, Endologix will be the leading innovator of treatments for aortic disorders. To Our Stockholders, Employees and Friends,
ADDENDUM NO. 2. Request for Quotation No
April 3, 2017 Michael Pacholok, Director Purchasing & Materials Management Division City Hall 100 Queen Street West 18 th Floor, West Tower Toronto, Ontario M5H 2N2 Elena Caruso, Manager of Purchasing,
Christian Reformed Church in North America Canadian Ministers Policy #
RBC Insurance Long Term Disability Income Protection Insurance Plan Highlights Christian Reformed Church in North America Canadian Ministers Policy # 580789 Please read carefully the following description
INVEST. Estimate your risk tolerance. saving : investing : planning
INVEST Estimate your risk tolerance saving : investing : planning Investing made easy Sometimes your financial picture can seem like the jumbled pieces of a jigsaw puzzle. Fortunately, your financial advisor
Measure Information Form
Measure Information Form Project Title: Vascular Access Project Overview: Date: The Centers for Medicare & Medicaid Services (CMS) has contracted with the University of Michigan Kidney Epidemiology and
UNIVERSITY OF CALIFORNIA GENERAL ENDOWMENT POOL INVESTMENT POLICY STATEMENT
Attachment 1 UNIVERSITY OF CALIFORNIA GENERAL ENDOWMENT POOL INVESTMENT POLICY STATEMENT POLICY SUMMARY/BACKGROUND The purpose of this Investment Policy Statement ( Policy or IPS ) is to define the objectives
Improved Tracheoesophageal Prosthesis Sizing in Office-Based Tracheoesophageal Puncture
Annals of Otology, Rhinology & Laryngology 119(1):37-41. 2010 Annals Publishing Company. All rights reserved. Improved Tracheoesophageal Prosthesis Sizing in Office-Based Tracheoesophageal Puncture Douglas
Transforming While We Grow Profitably
Transforming While We Grow Profitably Gary Maharaj President and CEO Andy LaFrence Vice President of Finance and CFO June 2015 2015 SurModics, Inc. 1 Safe Harbor Statement Some of the statements made during
Supplier briefing: Permanent Coronary Drug-Eluting Stents Market Share RFP Auckland 15 November 2017
Supplier briefing: Permanent Coronary Drug-Eluting Stents Market Share RFP Auckland 15 November 2017 Matthew Wolfenden Jacquie Pillay Sarah Fitt (Senior Procurement Manager) (Senior Device Category Manager)
TILA / RESPA Integrated Disclosures. The Game-changing Impacts and Action Items
TILA / RESPA Integrated Disclosures The Game-changing Impacts and Action Items CUNA Mutual Group Proprietary Reproduction, Adaptation or Distribution Prohibited CUNA Mutual Group 2013 Presenters Jon Bundy
Haematologic Technologies, Inc. Tube Requirements Form (rev ) Page 1 Initials
General Information Company/Institution: Investigator name: Contact name: Telephone: Fax: Email: Date: Product Information Number of tubes requested: Tube size: Tube material: Do you need a vacuum draw?
Financial Results for the Fiscal Year Ended March 31, 2017 (FY2016) and Guidance for the Fiscal Year Ending March 31, 2018 (FY2017)
Financial Results for the Fiscal Year Ended March 31, 2017 (FY2016) and Guidance for the Fiscal Year Ending March 31, 2018 (FY2017) Terumo Corporation Managing Executive Officer, Investor Relations, Corporate
Medtronic Public Limited Company Directors' Report and Financial Statements Financial Year Ended April 29, 2016
Medtronic Public Limited Company Directors' Report and Financial Statements Financial Year Ended April 29, 2016 TABLE OF CONTENTS Directors' Report Independent Auditors' Report Consolidated Profit and
AbbVie NJ. NASO-JEJUNAL TUBE with STYLET. For enteral use only Store at room temperature Rx Only. Do not re-use.
AbbVie NJ NASO-JEJUNAL TUBE with STYLET For enteral use only Store at room temperature 62903-001 Rx Only Catalog number Sterilized using ethylene oxide Do not re-use Do not use if package is damaged DESCRIPTION
Dynasil Corporation of America. Xcede Conference Call November 21, 2016
Dynasil Corporation of America Xcede Conference Call November 21, 2016 Forward-Looking Statements The statements made in this presentation which are not statements of historical fact are forward looking
Maintenance Instructions & Parts List
Maintenance Instructions Actuators Maintenance Instructions & Parts List Provide Model Number and Serial Number When Ordering Spare Parts. The PTR/LTR Series Actuators will provide superior performance
inc.jet Holding, Inc. CONSOLIDATED FINANCIAL STATEMENTS Years Ended March 31, 2018 and 2017
inc.jet Holding, Inc. CONSOLIDATED FINANCIAL STATEMENTS Years Ended March 31, 2018 and 2017 inc.jet Holding, Inc. March 31, 2018 and 2017 TABLE OF CONTENTS Page INDEPENDENT AUDITOR S REPORT 1 CONSOLIDATED
NOTES TO THE ACCOUNTS
1 Segment information Analysis by operating segment The Group is organised into five divisions:,,, and. These divisions design, manufacture and support the following products: mechanical seals, seal support
microvent mariner rescue resuscitator Price list parts January 2014
microvent mariner rescue resuscitator Price list parts January 2014 Document 117M Issue C dated 02 January 2014 (pin-index kit with BS schraeder fittings, medical oxygen) (pin-index kit with BS schraeder
THE NEW ANGLE GRINDERS WWB 200 PLUS / WWB 300 PLUS THE FIRST TO INCREASE OUTPUT ON THEIR OWN AND LOWER OPERATING COSTS. laska.at
THE NEW ANGLE GRINDERS WWB 200 PLUS / WWB 300 PLUS THE FIRST TO INCREASE OUTPUT ON THEIR OWN AND LOWER OPERATING COSTS. laska.at GREATER PERFORMANCE, GREATER HYGIENE, GREATER FLEXIBILITY. THE NEW GRINDERS
St. Jude Medical, Inc. $700,000, % Senior Notes due 2014 $500,000, % Senior Notes due 2019
Filed Pursuant to Rule 424(b)(2) Registration No. 333-160726 Title of Each Class of Securities to Be Registered Amount to Be Registered Proposed Maximum Offering Price Per Unit Proposed Maximum Aggregate
CTI INDUSTRIES FLEXIBLE FILM PRODUCTS FOR OUR WORLD Annual Report
CTI INDUSTRIES C O R P O R AT I O N FLEXIBLE FILM PRODUCTS FOR OUR WORLD 2014 Annual Report FOIL BALLOONS LATEX BALLOONS FLEXIBLE CONTAINERS VACUUM-SEALING SYSTEMS COMMERCIAL FILMS NASDAQ: CTIB Table of
ARTICLE I. Section 1. "City" shall mean the City of Marion, Linn County, Iowa.
RULES AND REGULATIONS GOVERNING THE MUNICIPAL WATER WORKS IN THE CITY OF MARION, IOWA, AND ADOPTED BY THE BOARD OF TRUSTEES OF THE MUNICIPAL WATER WORKS OF THE CITY OF MARION, IOWA. The following rules
Financial Tear Sheet. Corporate Profile. Primary IR Contact. Page 1/5
Financial Tear Sheet Corporate Profile We are a leading online consumer finance platform in China in terms of the outstanding principal balance of loans originated on our platform as of June 30, 2017,
TELEFLEX INCORPORATED (Exact name of registrant as specified in its charter)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended
List Price Sheet March 28, 2016
List Price Sheet March 28, 2016 Welcome to Clear Water Manufacturing In this booklet you will find products for the water and wastewater treatment industry. Whether you re involved in building water or
Social Benefits. Social Benefits. Paul Mason, Principal. IPSASB Meeting September 19-22, 2017 Toronto, Canada
Social Benefits Paul Mason, Principal IPSASB Meeting September 19-22, 2017 Toronto, Canada Page 1 Proprietary and Copyrighted Information Due Process (Agenda Item 5.2.1) Due Process Development of Proposed
Third Quarter 2011 Conference Call
Third Quarter 2011 Conference Call 28 October, 2011 SORIN GROUP Presentation 1 DISCLAIMER This presentation contains management preliminary estimates and forward-looking statements, including information